NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JMACCT ID: JMA-IIA00083

Registered date:13/03/2012

Clinical Trial of bilateral bevacizumab administration in patient with retinopathy of prematurity

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedretinopathy of prematurity
Date of first enrollment01/03/2012
Target sample size80
Countries of recruitmentJapan
Study typeINTERVENTIONAL
Intervention(s)Intervention type:DRUG. Intervention1:bevacizumab, Dose form:INJECTION, Route of administration:INTRA-OCULAR. Control intervention1:retinal photocoagulation, Dose form:DEVICE, Route of administration:INTRA-OCULAR.

Outcome(s)

Primary Outcomeretinal status. Timepoint:4 weeks, 8 weeks, 3 months, 6 months, 12 months.
Secondary Outcome.

Key inclusion & exclusion criteria

Age minimumNo Limit
Age maximum<=6 MONTHS
GenderBOTH
Include criteriaPatient with retinopathy of prematurity admitted in Miyazaki University Hospital
Exclude criterianone

Related Information

Contact

public contact
Name Eri Harae
Address Ophthalmology,5200 Kihara, Kiyotake-cho, Miyazaki-city, Miyazaki pref.
Telephone +81-985-85-2806
E-mail fukuyoshi0830@yahoo.co.jp
Affiliation School of Medicine, Miyazaki University
scientific contact
Name Nobuhisa Nao-i
Address Ophthalmology,5200 Kihara, Kiyotake-cho, Miyazaki-city, Miyazaki pref.
Telephone +81-985-85-2806
E-mail
Affiliation School of Medicine, Miyazaki University